USBio Logo

A3330-02E Rabbit Anti-ARF, p14 (p14ARF )

Specifications
References
Clone Type
Polyclonal
Host
Rabbit
Source
Human
Swiss Prot
Q8N726
Isotype
IgG
Grade
Affinity Purified
Applications
IF WB
Crossreactivity
Hu
Accession #
NP_478102.1
Shipping Temp
Blue Ice
Storage Temp
4°C Do not freeze

The INK4a-ARF locus is comprised of two tumor suppressors, p16INK4a and p14ARF. These two proteins are encoded through differential splicing of alternative first exons. The p16INK4a (exon 1alpha) protein inhibits the cyclin D-dependent kinases (CDK) that control the phosphorylation of the Rb protein and cell proliferation. The p14ARF gene product complexes with the MDM2 protein within the nucleus, thus modulating the activity of the p53 protein. P14ARF is a potent tumor suppressor in the presence of wild-type p53, while mutant p53 substantially reduces growth inhibition by p14ARF.

Applications
Suitable for use in Immunofluorescence, Western Blot, ELISA and Immunohistochemistry. Other applications not tested.
Recommended Dilution
Western Blot: 1:500-1:2500 ELISA: 1-100-1:2000 Immunohistochemistry (frozen/paraffin): 1:500-1:1000 Optimal dilutions to be determined by the researcher.
Positive Control
BT549 or HeLa whole cell extracts
Storage and Stability
May be stored at 4°C. For long-term storage, aliquot and store at 4°C. Do not freeze. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.
Immunogen
Synthetic peptide mapping to a fragment of residues within amino acids 75-125 of human p14ARF.
Form
Supplied as a liquid in Tris-Citrate/Phosphate, 0.09% sodium azide.
Purity
Purified by immunoaffinity chromatography.
Specificity
Recognizes human p14ARF.
References
Newcomb, E.W., et al. Incidence of p14ARF gene deletion in high-grade adult and pediatric astrocytomas. Human Pathology. 31(1): 115-9, 2000. Taniguchi, T., et al. Expression of p16INK4a and p14ARF in hematological malignancies. Leukemia. 13(11): 1760-9, 1999. Simon, M. et al. Functional evidence for a role of combined CDKN2A (p16-p14(ARF))/CDKN2A (p15) gene activation in malignant gliomas. Acta Neuropathol. 98(5): 444-52, 1999. Herbert, B., et al. p16INK4a inactivation is not required to immortalize human mammary epithelial cells. Oncogene. 21:7897-7900, 2002.
USBio References
No references available
Conjugates
Pricing
Order
Proceed to Checkout
Cart Summary
ProductSizeListYour PriceQtyExt Price
Subtotal:Subtotal:
Subtotal:Subtotal:
Total Coupon Savings:Total Coupon Savings:()
Your cart is currently empty.
- Coupon Code
Recently Viewed
Contact Us

Visit our technical library or contact our support staff to answer your questions.

Telephone:
1-800-520-3011

Library | Contact

Distributors

For customers outside of the United States, please use one of our many distributors.

View Distributors

Payment Methods

We accept the following payment methods as well as pay-by-invoice.

MasterCard Visa PayPal
© 2023-2024 United States Biological - All Rights Reserved